Risk of early recurrence among postmenop
✍
Hagen Kennecke; Heather McArthur; Ivo A. Olivotto; Caroline Speers; Chris Bajdik
📂
Article
📅
2008
🏛
John Wiley and Sons
🌐
English
⚖ 162 KB
👁 1 views
## Abstract ## BACKGROUND Adjuvant aromatase inhibitors (AIs), instead of or after tamoxifen, are effective in decreasing recurrence in postmenopausal women with estrogen receptor (ER)‐positive breast cancer. An understanding of which patients are at risk of early recurrence while they are receivi